Jordan Fredriksen Isaacs

Jordan received her B.A in Neuroscience and Economics from Smith College, where she played soccer and spent a semester abroad at the University of Oxford. Before starting graduate school, she worked in the laboratory of Dr. John Babich identifying affinity of radiolabeled drugs against prostate cancer antigens. The following summer, she interned in the Quantitative Biology Group at Eli Lilly assessing binding interactions of Alzheimer's associated proteins and potency of bispecific T cell engagers in cancer. Jordan started her graduate work at Dartmouth in 2018, where she initially studied the anti-tumor and immune-modulatory effects of a novel nuclear hormone receptor agonist in glioblastoma. Currently in Dr. Rosato's laboratory, her project focuses on understanding the role of CD39 in T cell immunity to brain tumors. Outside of the lab, Jordan loves spending time with family, cooking, playing soccer, and traveling.